May 5, 2020
Vigene viral vector and plasmid production technology webinar series
March 27, 2020
Vigene has joined the fight against COVID-19 by helping manufacture vaccines for COVID-19.
March 23, 2020
We would like to update you on the precautions and actions that Vigene Biosciences is taking due to the rapidly […]
February 27, 2020
BioBuzz reported on the grand opening of Vigene Biosciences’s new 51,000 square feet GMP manufacturing facility.
Vigene partners with Virovek for cGMP BAC-to-AAV production technology
Virovek has granted Vigene an exclusive cGMP license for their proprietary BAC-to-AAV production technology. AAV vectors generated from this scalable and efficient platform have been proven to infect and transduce a myriad of mammalian cell lines in vitro and a broad range of cell types in vivo.
Get the information you need from our guides and safety data sheets.
Citations & Testimonials
Find out how scientists are using our products and services.